Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Strategic application of radiotherapy for hepatocellular carcinoma

Seo Hee Choi, Jinsil Seong

Clin Mol Hepatol. 2018;24(2):114-134. Published online February 14, 2018

DOI: https://doi.org/10.3350/cmh.2017.0073

View: 14135 Download: 384 Web of Science: 36 Crossref: 41

Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend

Grace Lai-Hung Wong

Clin Mol Hepatol. 2018;24(2):108-113. Published online January 22, 2018

DOI: https://doi.org/10.3350/cmh.2017.0068

View: 12941 Download: 509 Web of Science: 37 Crossref: 39

Epidemiology of liver cancer in South Korea

Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol. 2018;24(1):1-9. Published online December 18, 2017

DOI: https://doi.org/10.3350/cmh.2017.0112

View: 14535 Download: 482 Web of Science: 133 Crossref: 136

Case Report

Complete response of advanced hepatocellular carcinoma to sorafenib : another case and a comprehensive review

Tae Suk Kim, Ji Hoon Kim, Baek hui Kim, Young-Sun Lee, Yang Jae Yoo, Seong Hee Kang, Sang-June Suh, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun

Clin Mol Hepatol. 2017;23(4):340-346. Published online June 20, 2017

DOI: https://doi.org/10.3350/cmh.2016.0070

View: 16085 Download: 198 Web of Science: 18 Crossref: 18

Review

Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system

Tae Kyoung Kim, Seung Yeon Noh, Stephanie R Wilson, Yuko Kono, Fabio Piscaglia, Hyun-Jung Jang, Andrej Lyshchik, Christoph F. Dietrich, Juergen K. Willmann, Alexander Vezeridis, Claude B Sirlin

Clin Mol Hepatol. 2017;23(4):280-289. Published online September 15, 2017

DOI: https://doi.org/10.3350/cmh.2017.0037

View: 15384 Download: 407 Web of Science: 86 Crossref: 88

Treatment options after sorafenib failure in patients with hepatocellular carcinoma

Imane El Dika, Ghassan K. Abou-Alfa

Clin Mol Hepatol. 2017;23(4):273-279. Published online November 20, 2017

DOI: https://doi.org/10.3350/cmh.2017.0108

View: 9112 Download: 232 Web of Science: 27 Crossref: 27

Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma

Edward Wolfgang Lee, Sarah Khan

Clin Mol Hepatol. 2017;23(4):265-272. Published online November 8, 2017

DOI: https://doi.org/10.3350/cmh.2017.0111

View: 10983 Download: 359 Web of Science: 39 Crossref: 35

Original Article

Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?

Linda L. Wong, Ruel J. Reyes, Sandi A. Kwee, Brenda Y. Hernandez, Sumodh C. Kalathil, Naoky C. Tsai

Clin Mol Hepatol. 2017;23(3):239-248. Published online July 14, 2017

DOI: https://doi.org/10.3350/cmh.2017.0008

View: 7757 Download: 143 Web of Science: 32 Crossref: 34

Editorial

Surveillance of hepatocellular carcinoma: is only ultrasound enough?

Woo Kyoung Jeong

Clin Mol Hepatol. 2017;23(3):222-223. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0046

View: 6515 Download: 162 Web of Science: 7 Crossref: 6

Original Article

Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B

Won Sohn, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, Yong-Han Paik

Clin Mol Hepatol. 2017;23(2):170-178. Published online May 16, 2017

DOI: https://doi.org/10.3350/cmh.2016.0086

View: 9424 Download: 221 Web of Science: 50 Crossref: 44

Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion

Jihyun An, Kwang Sun Lee, Kang Mo Kim, Do Hyun Park, Sang Soo Lee, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2017;23(2):160-169. Published online May 16, 2017

DOI: https://doi.org/10.3350/cmh.2016.0088

View: 8730 Download: 239 Web of Science: 31 Crossref: 26

Meta-analysis of the correlation between the rs17401966 polymorphism in kinesin family member 1B and susceptibility to hepatitis B virus related hepatocellular carcinoma

Mingkuan Su, Jianfeng Guo, Jiancheng Huang

Clin Mol Hepatol. 2017;23(2):138-146. Published online April 21, 2017

DOI: https://doi.org/10.3350/cmh.2016.0083

View: 9008 Download: 112 Web of Science: 4 Crossref: 3

A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function

Hyun Yang, Hyun Young Woo, Soon Kyu Lee, Ji Won Han, Bohyun Jang, Hee Chul Nam, Hae Lim Lee, Sung Won Lee, Do Seon Song, Myeong Jun Song, Jung Suk Oh, Ho Jong Chun, Jeong Won Jang, Angelo Lozada, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon

Clin Mol Hepatol. 2017;23(2):128-137. Published online May 10, 2017

DOI: https://doi.org/10.3350/cmh.2016.0071

View: 11470 Download: 190 Web of Science: 24 Crossref: 21

Editorial

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?

Do Young Kim

Clin Mol Hepatol. 2017;23(2):123-124. Published online June 23, 2017

DOI: https://doi.org/10.3350/cmh.2017.0107

View: 6800 Download: 118

Review

Radioembolization for the treatment of hepatocellular carcinoma

Hyo-Cheol Kim

Clin Mol Hepatol. 2017;23(2):109-114. Published online May 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0004

View: 12288 Download: 362 Web of Science: 46 Crossref: 41

Liver Imaging

Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma

Tae Wook Kang, Hyo Keun Lim, Dong Ik Cha

Clin Mol Hepatol. 2017;23(1):95-101. Published online March 24, 2017

DOI: https://doi.org/10.3350/cmh.2017.0006

View: 11112 Download: 257 Web of Science: 39 Crossref: 35

Original Article

A lexicon for hepatocellular carcinoma surveillance ultrasonography: benign versus malignant lesions

Chansik An, Gulbahor Rakhmonova, Kyunghwa Han, Nieun Seo, Jin Young Lee, Myeong-Jin Kim, Mi-Suk Park

Clin Mol Hepatol. 2017;23(1):57-65. Published online March 24, 2017

DOI: https://doi.org/10.3350/cmh.2016.0041

View: 14138 Download: 190 Web of Science: 2 Crossref: 2

The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE

Jung Hee Kim, Dong Hyun Sinn, Sung Wook Shin, Sung Ki Cho, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Moon Seok Choi

Clin Mol Hepatol. 2017;23(1):42-50. Published online March 7, 2017

DOI: https://doi.org/10.3350/cmh.2016.0058

View: 9978 Download: 215 Web of Science: 12 Crossref: 11

Editorial

Is scheduled second chemoembolization necessary for early stage hepatocellular carcinoma showing complete response after first chemoembolization?

Jin Wook Chung

Clin Mol Hepatol. 2017;23(1):31-33. Published online March 16, 2017

DOI: https://doi.org/10.3350/cmh.2017.0102

View: 6002 Download: 104 Web of Science: 1 Crossref: 1

Liver Imaging

Percutaneous cryoablation for hepatocellular carcinoma

Kyoung Doo Song

Clin Mol Hepatol. 2016;22(4):509-515. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0079

View: 11968 Download: 210 Web of Science: 38 Crossref: 41

Original Article

Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma

Ju-Yeon Cho, Moon Seok Choi, Gil Sun Lee, Won Sohn, Jemma Ahn, Dong-Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik

Clin Mol Hepatol. 2016;22(4):477-486. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0048

View: 9068 Download: 156 Web of Science: 23 Crossref: 21

Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization

Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi

Clin Mol Hepatol. 2016;22(4):458-465. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0054

View: 8799 Download: 134 Web of Science: 9 Crossref: 9

Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma

Lauren M. Ladd, Temel Tirkes, Mark Tann, David M. Agarwal, Matthew S. Johnson, Bilal Tahir, Kumaresan Sandrasegaran

Clin Mol Hepatol. 2016;22(4):450-457. Published online December 14, 2016

DOI: https://doi.org/10.3350/cmh.2016.0036

View: 8985 Download: 157 Web of Science: 6 Crossref: 5

Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis

Yejoo Jeon, Eun Sun Jang, Yun Suk Choi, Jin-Wook Kim, Sook-Hyang Jeong

Clin Mol Hepatol. 2016;22(3):359-365. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0033

View: 12065 Download: 145 Web of Science: 20 Crossref: 19

Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B

Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park

Clin Mol Hepatol. 2016;22(3):339-349. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0021

View: 11589 Download: 162 Web of Science: 19 Crossref: 19

Editorial

Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?

Byoung Kuk Jang

Clin Mol Hepatol. 2016;22(3):336-338. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0104

View: 7903 Download: 115 Web of Science: 2 Crossref: 1

Review

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy

Ioannis Varbobitis, George V. Papatheodoridis

Clin Mol Hepatol. 2016;22(3):319-326. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0045

View: 13248 Download: 393 Web of Science: 67 Crossref: 68

Liver transplantation for advanced hepatocellular carcinoma

Hae Won Lee, Kyung-Suk Suh

Clin Mol Hepatol. 2016;22(3):309-318. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0042

View: 12222 Download: 268 Web of Science: 22 Crossref: 21

Liver Imaging

Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm

Chansik An, Gulbahor Rakhmonova, Jin-Young Choi, Myeong-Jin Kim

Clin Mol Hepatol. 2016;22(2):296-307. Published online June 15, 2016

DOI: https://doi.org/10.3350/cmh.2016.0028

View: 12530 Download: 237 Web of Science: 46 Crossref: 40

Case Report

Bone marrow metastasis presenting as bicytopenia originating from hepatocellular carcinoma

Young Mi Hong, Ki Tae Yoon, Mong Cho, Dae Hwan Kang, Hyung Wook Kim, Cheol Woong Choi, Su Bum Park, Jeong Heo, Hyun Young Woo, Won Lim, SM Bakhtiar UI Islam

Clin Mol Hepatol. 2016;22(2):267-271. Published online May 16, 2016

DOI: https://doi.org/10.3350/cmh.2015.0017

View: 12338 Download: 161 Web of Science: 6 Crossref: 7

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next

Viewed By 5561	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4768	MAFLD: How is it different from NAFLD?
Viewed By 4486	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3680	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3657	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 80	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search